2018年保加利亚痴呆症和阿尔茨海默病的流行情况:全国代表性研究
Evgeniy Krastev1, Ralitsa Krasteva2, Mario Fazli1
1Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridski, Bulgaria.
Studies in health technology and informatics
|August 23, 2024
概括
这项研究使用大量患者数据集在保加利亚确定了痴呆症和阿尔茨海默病的患病率. 痴呆症影响1.61%,阿尔茨海默病影响0.39%的患者,老年人的发病率更高.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 在保加利亚,痴呆症和阿尔茨海默病的确切流行数据有限.
- 需要有关痴呆症和阿尔茨海默病患者数量的国家统计数据.
研究的目的:
- 确定保加利亚痴呆症和阿尔茨海默病的确切流行率.
- 分析疾病流行中的人口结构模式 (年龄,性别).
主要方法:
- 对来自642013名独特患者 (2018年) 的大量数据集 (1378355条记录) 的分析.
- 将伪名的门诊病例记录映射到OMOP共同数据模型 (CDM) 关系数据库中.
- 计算不同年龄组和性别的流行率.
主要成果:
- 整体痴呆的患病率: 1.61% (0.62%男性,0.99%女性).
- 总体阿尔茨海默病的患病率:0.39% (0.15%男性,0.24%女性).
- 在64岁以上的人群中,痴呆的患病率为9.52%,阿尔茨海默病的患病率为1.04%.
结论:
- 确定了保加利亚痴呆症和阿尔茨海默病的基线流行率.
- 结果与欧盟数据中观察到的已知的衰老和性别特异性模式一致.
- 这些发现支持制定国家痴呆症和阿尔茨海默病战略.
相关概念视频
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Prevalence and Incidence
397
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
397


